Abstract:Macrolides are widely prescribed in clinic to treat various respiratory tract infections. However, due to their inappropriate use, the prevalence of macrolide-resistant strains among clinical isolates has become a concern for public health. Therefore, novel macrolides skeleton structures against resistant pathogens are badly needed. Thus, three series of novel 15-membered 11a-azahomoclarithromycin derivatives (series A-C) with the 1, 2, 3-triazole side chain were designed and synthesized through creatively opening the ring of clarithromycin (CAM), expanding the ring properly and introducing a suitable side chain of 1, 2, 3-triazole at the C12 and C13 positions, and evaluated for their antibacterial activity. The antibacterial results indicated that compounds 38b, 38l and 38v possessed strong antibacterial activity against Staphylococcus aureus ATCC25923 (0.25 μg/mL) and Bacillus subtilis ATCC9372 (0.25 μg/mL). Furthermore, compounds 9e and 38g were found to exhibit promising potent activity (8 μg/mL) against Streptococcus pneumonia AB11 expressing the ermB and mefA genes. In addition, the determination of minimum bactericidal concentration (MBC) indicated that the most promising compounds 38b, 38l, 38v, 9e and 38g were excellent bacteriostatic agents. The bactericidal curve showed that 9e exhibited antibacterial activity through bacteriostatic mechanism. Finally, 38b, 38l and 38v were confirmed to be non-toxic to MCF-7 breast cancer cells up to a concentration of 32 μg/mL in preliminary cytotoxicity assay. In summary, 38b, 38l, 38v, 9e and 38g can be served as lead compounds to provide a new perspective for further structural optimization.

Novel C-4″ Modified Azithromycin Analogs with Remarkably Enhanced Activity Against Erythromycin-Resistant Streptococcus Pneumoniae: the Synthesis and Antimicrobial Evaluation

Synthesis and Antibacterial Activity of Novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) Azithromycin Analogs.

Synthesis and Antibacterial Evaluation of Novel 11,4″-Disubstituted Azithromycin Analogs with Greatly Improved Activity Against Erythromycin-Resistant Bacteria.

Synthesis and Antibacterial Activity of Novel 15-Membered Macrolide Derivatives: 4″-Carbamate, 11,12-Cyclic Carbonate-4″-carbamate and 11,4″-Di-o-arylcarbamoyl Analogs of Azithromycin

Synthesis and Antibacterial Activity of Novel 3-O-carbamoyl Derivatives of Clarithromycin and 11,12-Cyclic Carbonate Azithromycin

Novel Clarithromycin Analogs with C-4&#x201D; 2-Arylbenzimidazolyl Bishydrazide Side Chain: Synthesis and Antibacterial Evaluation

Synthesis and Antibacterial Evaluation of Novel Clarithromycin Derivatives with C-4″ Elongated Arylalkyl Groups Against Macrolide-Resistant Strains.

Synthesis and Antibacterial Activity of Novel 11-O-phenethylcarbamoylazithromycin Derivatives with 4 ''-Elongated Side Chains

Synthesis and Antibacterial Activity of 4″,11-Di-o-arylalkylcarbamoyl Azithromycin Derivatives

Synthesis and Antibacterial Activity of Novel 4"-O-carbamoyl Erythromycin-A Derivatives

Synthesis and antibacterial activity of 4″- O -(trans- β -arylacrylamido)carbamoyl azithromycin analogs

Synthesis and antibacterial activity of 4″-O-carbamoyl analogs of clarithromycin

Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives

Synthesis and Antibacterial Activity of New 4″-O-carbamates of 11,12-Cyclic Carbonate Erythromycin A 6,9-Imino Ether

Synthesis and Antibacterial Activity of Novel 3-O-descladinosylazithromycin Derivatives

Synthesis and antibacterial activity of novel 4″-O-benzimidazolyl clarithromycin derivatives.

Synthesis and Antibacterial Evaluation of Novel 11-O-aralkylcarbamoyl-3-o-descladinosylclarithromycin Derivatives

Synthesis and Antibacterial Activity of Novel 3-O-arylalkylcarbamoyl-3-o-descladinosyl-9-o-(2-chlorobenzyl)oxime Clarithromycin Derivatives

Design, Synthesis and Antibacterial Evaluation of Novel 15-Membered 11A-Azahomoclarithromycin Derivatives with the 1, 2, 3-Triazole Side Chain.

Synthesis and antibacterial activity of novel 4|[Prime]|-carbamates of 6,11-di-O-methylerythromycin A

Synthesis and Antibacterial Activity of 11,12-Cyclic Carbonate 4″-O-aralkylacetylhydrazineacyl Azithromycin Derivatives